| Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant–antioxidant system in patients with psoriasis BV Kural, A Örem, G Çimşit, YE Yandı, M Calapoǧlu Clinica chimica acta 328 (1-2), 71-82, 2003 | 241 | 2003 |
| Clustering according to urolithin metabotype explains the interindividual variability in the improvement of cardiovascular risk biomarkers in overweight‐obese individuals … A González‐Sarrías, R García‐Villalba, M Romo‐Vaquero, C Alasalvar, ... Molecular nutrition & food research 61 (5), 1600830, 2017 | 212 | 2017 |
| Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients BV Kural, A Örem, G Çimşit, HA Uydu, YE Yandi, A Alver Clinica Chimica Acta 332 (1-2), 23-30, 2003 | 162 | 2003 |
| The gut microbiota metabolism of pomegranate or walnut ellagitannins yields two urolithin-metabotypes that correlate with cardiometabolic risk biomarkers: Comparison between … MV Selma, A González-Sarrías, J Salas-Salvadó, C Andrés-Lacueva, ... Clinical Nutrition 37 (3), 897-905, 2018 | 141 | 2018 |
| Hazelnut-enriched diet improves cardiovascular risk biomarkers beyond a lipid-lowering effect in hypercholesterolemic subjects A Orem, FB Yucesan, C Orem, B Akcan, BV Kural, C Alasalvar, F Shahidi Journal of clinical lipidology 7 (2), 123-131, 2013 | 110 | 2013 |
| Prognostic value of red cell distribution width in patients with pulmonary embolism S Ozsu, Y Abul, S Gunaydin, A Orem, T Ozlu Clinical and Applied Thrombosis/Hemostasis 20 (4), 365-370, 2014 | 105 | 2014 |
| Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing–remitting multiple sclerosis treated with interferon beta C Boz, M Ozmenoglu, S Velioglu, K Kilinc, A Orem, Z Alioglu, ... Clinical neurology and neurosurgery 108 (2), 124-128, 2006 | 105 | 2006 |
| Effect of antiepileptic drugs on plasma lipids, lipoprotein (a), and liver enzymes F Mujgan Sonmez, E Demir, A Orem, S Yildirmis, F Orhan, A Aslan, ... Journal of child neurology 21 (1), 70-74, 2006 | 104 | 2006 |
| How does colistin-induced nephropathy develop and can it be treated? G Ozkan, S Ulusoy, A Orem, M Alkanat, S Mungan, E Yulug, FB Yucesan Antimicrobial agents and chemotherapy 57 (8), 3463-3469, 2013 | 103 | 2013 |
| Decreased nitric oxide production in patients with Behçet’s disease A Örem, B Vanizor, G Cimşit, E Kıran, O Değer, M Malkoç Dermatology 198 (1), 33-36, 1999 | 99 | 1999 |
| The effects of lipid-lowering therapy on paraoxonase activities and their relationships with the oxidant–antioxidant system in patients with dyslipidemia BV Kural, C Örem, HA Uydu, A Alver, A Örem Coronary Artery Disease 15 (5), 277-283, 2004 | 88 | 2004 |
| The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels … A Örem, YE Yandi, B Vanizor, G Çimşit, HA Uydu, M Malkoç Clinical Biochemistry 35 (3), 217-224, 2002 | 81 | 2002 |
| Relationship between lipid peroxidation and disease activity in patients with Behçet's disease A Örem, H Efe, O Deǧer, G Çimşit, HA Uydu, B Vanizor Journal of dermatological science 16 (1), 11-16, 1997 | 68 | 1997 |
| Protective effect of the grape seed proanthocyanidin extract in a rat model of contrast-induced nephropathy G Ozkan, S Ulusoy, A Orem, S Ersoz, M Alkanat, FB Yucesan, K Kaynar, ... Kidney and Blood Pressure Research 35 (6), 445-453, 2013 | 64 | 2013 |
| Plasma lipoprotein (a) concentrations in hypothyroid, euthyroid and hyperthyroid subjects. C Erem, O Değer, M Bostan, A Orem, M Sönmez, S Ulusoy, M Telatar Acta cardiologica 54 (2), 77-81, 1999 | 62 | 1999 |
| Hazelnut consumption decreases the susceptibility of LDL to oxidation, plasma oxidized LDL level and increases the ratio of large/small LDL in normolipidemic healthy subjects … FB Yücesan, A Örem, BV Kural, C Örem, İ Turan The Anatolian Journal of Cardiology 10 (1), 28, 2010 | 61 | 2010 |
| Decreased nitric oxide end-products and its relationship with high density lipoprotein and oxidative stress in people with type 2 diabetes without complications B Vanizor, A Örem, SC Karahan, E Kiran, C Erem, R Aliyazicioğlu, ... Diabetes research and clinical practice 54 (1), 33-39, 2001 | 61 | 2001 |
| Prevalence of metabolic syndrome in patients with mucosal lichen planus: A case–control study L Baykal, DA Arıca, S Yaylı, A Örem, S Bahadır, E Altun, H Yaman American journal of clinical dermatology 16, 439-445, 2015 | 57 | 2015 |
| The effects of lipid-lowering therapy on low-density lipoprotein auto-antibodies: relationship with low-density lipoprotein oxidation and plasma total antioxidant status C Örem, A Örem, HA Uydu, S Çelik, C Erdöl, BV Kural Coronary artery disease 13 (1), 65-71, 2002 | 56 | 2002 |
| Effect of antiepileptic drugs on plasma lipoprotein (a) and other lipid levels in childhood F Müjgan Aynaci, F Orhan, A Orem, S Yildirmis, Y Gedik Journal of child neurology 16 (5), 367-369, 2001 | 56 | 2001 |
Orhan DegerTıbbi Biyokimya Profesörü, Karadeniz Teknik ÜniversitesiVerified email at ktu.edu.tr
